← 產業報告目錄

Legionella Testing Market Size, Share & Trends Analysis Report By Test Type (Culture, Urine Antigen Test (UAT), Direct Fluorescent Antibody (DFA) Test), By End-Use (Hospitals & Clinics, Diagnostics Laboratories, Water Treatment Industries), By Region, And By Segment Forecasts, 2023-2031

出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-03-10頁數 180報告編號 INSIGHTACE-548f297927

授權報價

Single User PDF$4,500 USD
Global Site License PDF$9,500 USD
洽詢購買 申請 Sample

報告摘要

Valued at USD 295.21 Mn as of 2022, the global Legionella Testing Market is set to climb to USD 551.37 Mn by 2031, reflecting a compound annual growth rate of 7.3% over the 2023–2031 period. Legionella Testing encompasses challenges. Growth is bolstered by a convergence of factors: rising awareness among end users, continuous product innovation, and the rising emphasis on efficiency and sustainability within the healthcare sector. From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities. Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, bolstered by rapid industrialization and expanding end-user bases. Industry participants are deploying a range of strategies—including partnerships, mergers, technological investments, and portfolio diversification—to consolidate their market standing. Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope 1.1. Research Methodology 1.2. Research Scope & Assumptions Chapter 2. Executive Summary Chapter 3. Global Legionella Testing Market Snapshot Chapter 4. Global Legionella Testing Market Variables, Trends & Scope 4.1. Market Segmentation & Scope 4.2. Drivers 4.3. Challenges 4.4. Trends 4.5. Investment and Funding Analysis 4.6. Industry Analysis – Porter's Five Forces Analysis 4.7. COVID-19 Impact Analysis Chapter 5. Market Segmentation 1: Test Type Estimates & Trend Analysis 5.1. Test Type & Market Share, 2019-2031 5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following Test Type: 5.2.1. Culture 5.2.2. Urine Antigen Test (UAT) 5.2.3. Direct Fluorescent Antibody (DFA) Test 5.2.4. Polymerase Chain Reaction (PCR) 5.2.5. Others Chapter 6. Market Segmentation 2: By End Use Estimates & Trend Analysis 6.1. Test Type & Market Share, 2019-2031 6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following By End Use: 6.2.1. Hospitals and clinics 6.2.2. Diagnostic Laboratories 6.2.3. Water Treatment Industries Chapter 7. Legionella Testing Market Segmentation 3: Regional Estimates & Trend Analysis 7.1. North America 7.1.1. North America Legionella Testing Market revenue (US$ Million) estimates and forecasts Test Type, 2023-2031 7.1.2. North America Legionella Testing Market revenue (US$ Million) estimates and forecasts By End Use, 2023-2031 7.1.3. North America Legionella Testing Market revenue (US$ Million) estimates and forecasts by country, 2023-2031 7.1.3.1. U.S. 7.1.3.2. Canada 7.2. Europe 7.2.1. Europe Legionella Testing Market revenue (US$ Million) Test Type, 2023-2031 7.2.2. Europe Legionella Testing Market revenue (US$ Million) By End Use, 2023-2031 7.2.3. Europe Legionella Testing Market revenue (US$ Million) by country, 2023-2031 7.2.3.1. Germany 7.2.3.2. Poland 7.2.3.3. France 7.2.3.4. Italy 7.2.3.5. Spain 7.2.3.6. UK 7.2.3.7. Rest of Europe 7.3. Asia Pacific 7.3.1. Asia Pacific Legionella Testing Market revenue (US$ Million) Test Type, 2023-2031 7.3.2. Asia Pacific Legionella Testing Market revenue (US$ Million) By End Use, 2023-2031 7.3.3. Asia Pacific Legionella Testing Market revenue (US$ Million) by country, 2023-2031 7.3.3.1. China 7.3.3.2. India 7.3.3.3. Japan 7.3.3.4. Australia 7.3.3.5. Rest of Asia Pacific 7.4. Latin America 7.4.1. Latin America Legionella Testing Market revenue (US$ Million) Test Type, 2023-2031 7.4.2. Latin America Legionella Testing Market revenue (US$ Million) By End Use, 2023-2031 7.4.3. Latin America Legionella Testing Market revenue (US$ Million) by country, (US$ Million) 2023-2031 7.4.3.1. Brazil 7.4.3.2. Rest of Latin America 7.5. Middle East & Africa 7.5.1. Middle East & Africa Legionella Testing Market revenue (US$ Million) Test Type, (US$ Million) 7.5.2. Middle East & Africa Legionella Testing Market revenue (US$ Million) By End Use, (US$ Million) 7.5.3. Middle East & Africa Legionella Testing Market revenue (US$ Million) by country, (US$ Million) 2023-2031 7.5.3.1. South Africa 7.5.3.2. GCC Countries 7.5.3.3. Rest of MEA Chapter 8. Competitive Landscape 8.1. Major Mergers and Acquisitions/Strategic Alliances 8.2. Company Profiles 9.2.1. Thermo Fisher Scienific, Inc. (US) 9.2.2. Merck KGaA (Germany) 9.2.3. Becton, Dickinson, and Company (US) 9.2.4. Roche Diagnostics (Switzerland) 9.2.5. Pall Corporation (US) 9.2.6. Pro-lab Diagnostics Inc. 9.2.7. Beckman Coulter Inc. 9.2.8. Bio-Rad Laboratories Inc. 9.2.9. Alere Inc. (Abbott Rapid Diagnostics) 9.2.10. Eiken Chemical Co. Ltd. 9.2.11. Hologic Inc. 9.2.12. QIAGEN 9.2.13. Takara Bio Inc. 9.2.14. Environmental Safety Technologies Inc. 9.2.15. Hydrosense 9.2.16. Accepta Ltd. 9.2.17. LuminUltra Technologies Ltd. 9.2.18. Pro-Lab Diagnostics Inc. 9.2.19. BioAlert Solutions 9.2.20. Pacific Water Technology 9.2.21. Aquacert Ltd. 9.2.22. DTK Water 9.2.23. Sens Solutions 9.2.24. Genomadix Inc. 9.2.25. Phigenics LLC 9.2.26. Other Prominent Players

量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們